DMAC compared with WHK: revenue, margins and what each company keeps, and the suppliers and customers both name

DMACDiaMedica Therapeutics Inc.

Mkt capRevenueRevenue

WHKWhiteHawk Minerals Corp.

Mkt capRevenueRevenue

Compare

DMACDiaMedica Therapeutics Inc.

WHKWhiteHawk Minerals Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DMAC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.9%▲+3.31%×0.21

May 7 '26±36.3%▲+0.15%×0.00

Q1 FY26±22.1%▲+1.96%×0.09

Q3 FY25±19.8%▼−14.10%×0.71

WHK

No earnings history for WHK.

= impliedDMAC realized, solidWHK realized, hatchedOne scale, both sides: full bar = 37%× = |realized| ÷ impliedSource: market data

DMACDiaMedica Therapeutics Inc.

9.27▼−2.68%· post 9.26

Mkt cap$498.8MRevenue—

WHKWhiteHawk Minerals Corp.

26.26▼−0.44%· post 26.26

ClosedOct 30 '26

Mkt cap$450.0MRevenue$29MQ2 FY26

Compare

ClosedOct 30 '26

DMACDiaMedica Therapeutics Inc.

WHKWhiteHawk Minerals Corp.

9.27▼−2.68%post 9.26

Price

26.26▼−0.44%post 26.26

$498.8M

Mkt cap

$450.0M

—

Revenue

$29MQ2 FY26

DMAC9.27▼−2.68%vsWHK26.26▼−0.44%ClosedOct 30 '26